Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

JOURNAL ARTICLE published 7 July 2022 in New England Journal of Medicine

Research funded by Daiichi Sankyo (N/A) | AstraZeneca (N/A)

Authors: Shanu Modi | William Jacot | Toshinari Yamashita | Joohyuk Sohn | Maria Vidal | Eriko Tokunaga | Junji Tsurutani | Naoto T. Ueno | Aleix Prat | Yee Soo Chae | Keun Seok Lee | Naoki Niikura | Yeon Hee Park | Binghe Xu | Xiaojia Wang | Miguel Gil-Gil | Wei Li | Jean-Yves Pierga | Seock-Ah Im | Halle C.F. Moore | Hope S. Rugo | Rinat Yerushalmi | Flora Zagouri | Andrea Gombos | Sung-Bae Kim | Qiang Liu | Ting Luo | Cristina Saura | Peter Schmid | Tao Sun | Dhiraj Gambhire | Lotus Yung | Yibin Wang | Jasmeet Singh | Patrik Vitazka | Gerold Meinhardt | Nadia Harbeck | David A. Cameron